PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MD Anderson research highlights for January 25, 2024

Featuring combination therapies for KRAS¬-mutant colorectal cancer, prognostic tools for lung cancer, gold nanoparticles, and insights into progression and treatment response

2024-01-25
(Press-News.org) HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

Recent developments at MD Anderson include a combination treatment for KRAS G12C-mutant colorectal cancer; using liquid biopsies to classify small-cell lung cancer subtypes; an artificial intelligence model to improve non-small cell lung cancer classification; a novel method of delivering gold ions into tumors to improve radiation sensitivity; molecular insights into age-related inflammation; improved outcomes for certain patients with multiple myeloma receiving stem cell transplants; a new understanding of why tumors from the appendix metastasize to the peritoneal cavity; and trial results of circulating tumor DNA as a predictive biomarker for adjuvant therapy response in patients with low-risk colon cancer.

Combining sotorasib and panitumumab shows early antitumor activity in KRAS G12C-mutant colorectal cancer
Current third-line and later treatment options for RAS-mutant metastatic colorectal cancer have shown only limited effectiveness. In a Phase Ib trial of 48 patients, researchers led by David S. Hong, M.D., found that the combination of sotorasib, a KRAS G12C inhibitor, and panitumumab, an EGFR inhibitor, showed promising efficacy in a subset of patients with KRAS G12C mutations. In the dose expansion cohort of 40 patients, the disease control rate was 93% and the tumor shrinkage rate was 88%, with a median progression-free survival and overall survival of 5.7 months and 15.2 months, respectively. None of the patients experienced dose-limiting toxicities, and grade three treatment-related adverse events were mostly dermatologic, occurring in 27% of patients. These results suggest this combination therapy has potential for patients with chemotherapy-refractory KRAS G12C-mutated metastatic colorectal cancer. Learn more in Nature Medicine.

Biomarkers from tumor and blood samples aid in lung cancer subtype classification   
Small-cell lung cancer (SCLC) has four distinct disease subtypes, but categorizing these groups has been challenging due to limited available tissue samples. Recent studies indicate that liquid biopsies, or blood tests, can use DNA methylation status to develop prognostic signatures and identify unique vulnerabilities in various cancers, including SCLC. To this end, researchers led by Simon Heeke, Ph.D., Lauren Byers, M.D., and John Heymach, M.D., Ph.D., studied transcriptomics and DNA methylation sequencing from 179 patients with SCLC. Using machine learning approaches, they developed a classification system that can distinguish among SCLC subtypes. By examining DNA methylation status from both tumor and circulating-free DNA in liquid biopsy samples, the researchers showed that tumors can evolve during disease progression, highlighting the importance of monitoring patients over the course of their treatments. The study suggests that using DNA methylation-based biomarkers from tumor or blood samples is a viable method of classifying and tailoring personalized care for patients with unique SCLC subtypes. Learn more in Cancer Cell. 

AI model provides insights into lung cancer severity and prognosis  
Lung adenocarcinoma (LUAD), the most common type of non-small cell lung cancer, has unique growth patterns that impact prognosis. Current International Association for the Study of Lung Cancer (IASLC) grading systems face challenges in consistently defining and recognizing these patterns, affecting accuracy and leading to variability among pathologists. In this study, researchers led by Yinyin Yuan, Ph.D., and Xiaoxi Pan, Ph.D., created a first-of-its kind artificial intelligence (AI)-based model, ANORAK, which dissects LUAD growth patterns at pixel level to better predict disease-free survival and prognosis of early-stage LUAD tumors. This technology, tested in 1,372 LUAD cases across four independent cohorts, provides an unbiased and automated pipeline for determining tumor grading in patients with LUAD. The AI model also offers insights into the diverse features of LUAD that cannot be determined by traditional classification methods, highlighting the need for improved quantification methods for this patient population. Learn more in Nature Cancer.

New approach uses gold ions to enhance radiotherapy efficacy in pancreatic tumors
Gold nanoparticles have shown potential for treating cancer by enhancing photothermal and radiation treatments as well as helping with drug and gene delivery to specific locations. However, delivering these nanoparticles to tumors and directly into cancer cells is challenging, particularly in solid pancreatic tumors. To overcome this barrier, Aaron Schwartz-Duval, Ph.D., Konstantin Sokolov, Ph.D., and colleagues devised a strategy using gold ions, which can more easily penetrate tissue, instead of nanoparticles. These ions form gold nanoparticles inside cancer cells through a natural process called biomineralization. In the study, this sensitized pancreatic cancer to radiotherapy and suppressed tumor growth, resulting in improved survival compared to radiation alone. These results show that using gold biomineralization leverages existing biological pathways to improve the efficacy of radiotherapy, meriting further investigation. Learn more in ACS Nano.

TXNRD1 enzyme drives innate immune response in senescent cells, with implications for aging and cancer
Chronic inflammation associated with aging – called inflammaging – contributes to cancer development and progression. Cellular senescence, a state in which cells have lost their ability to divide and multiply, also regulates cancer and tissue aging by secreting proinflammatory factors. There is evidence to suggest that TXNRD1, an enzyme regulating cellular redox, is implicated in tissue aging. In a new study, Rugang Zhang, Ph.D., and colleagues discovered that TXNRD1 drives inflammaging through the cGAS-STING pathway in a senescence-dependent manner that is distinct from its activity as a redox enzyme. Blocking the TXNRD1 interaction with cGAS using a specific inhibitor lowered markers of inflammaging in preclinical models, suggesting that the TXNRD1-cGAS interaction is a potential therapeutic target for both tissue aging and cancer. Learn more in Nature Aging.

Subset of patients with multiple myeloma have better outcomes after autologous stem cell transplant
According to a new study, newly diagnosed multiple myeloma (NDMM) patients harboring additional copies of chromosome 1q, a cytogenetic abnormality, have better outcomes than patients with other high-risk cytogenetic abnormalities when treated with an autologous stem cell transplant (autoSCT). Researchers led by Oren Pasvolsky, M.D., and Muzaffar Qazilbash, M.D., conducted a retrospective analysis of patients with NDMM treated with an autoSCT at MD Anderson. At 100 days post-transplant, 78% of patients achieved a very good partial response or better, and 38% achieved minimal residual disease (MRD)-negative very good response or better. Overall, 87% of patients achieved a very good partial response or better and 50% achieved MRD-negative very good response or better. A combination of bortezomib, lenalidomide and dexamethasone was the most common induction regimen, used in 41% of patients. Progression free survival was 2.9 years and overall survival was 6.7 years, both better than what is reported with other high-risk abnormalities. Learn more in Blood Cancer Journal.  

Study uncovers why tumors from appendix metastasize to peritoneal cavity
Appendix tumors usually metastasize to the peritoneal cavity – the space between the diaphragm, walls of the abdominal and pelvic cavities, and abdominal organs – but why this occurs remains unknown. To provide greater insight into this process, researchers led by Vinay Pattalachinti, Ichiaki Ito, Ph.D., and John Paul Shen, M.D., took a multi-omics approach to compare several models of appendix tumors implanted into both the flank and the peritoneal space of laboratory models. The results showed that peritoneal implanted tumors grew faster and had a higher expression of known cancer proliferation markers as well as the downregulation of a signaling pathway that triggers cell death. By identifying specific ways in which the peritoneal microenvironment promotes appendix cancer growth, this study opens new possibilities for potential treatments of this orphan disease. Learn more in Molecular Cancer Research.

Circulating tumor DNA not predictive of adjuvant chemotherapy response in patients with low-risk colon cancer
The presence of circulating tumor DNA (ctDNA) in patients with colon cancer after surgical resection has been associated with persistent disease and can serve as a prognostic marker for risk of recurrence. In a Phase II trial examining ctDNA to predict treatment response to adjuvant chemotherapy for low-risk stage II colon cancer, researchers led by Van Morris, M.D., randomized 636 patients into two cohorts. One group received standard of care and the other received chemotherapy if ctDNA was detected via a tumor-agnostic assay. The primary objective was to compare ctDNA clearance after 6 months among patients with detectable ctDNA at baseline. At the analysis of the Phase II endpoint, only 11% of patients in the chemotherapy arm had ctDNA clearance after 6 months compared with 43% of patients in the surveillance arm. Because the primary endpoint was not met, investigators stopped enrollment on the study. This was the first National Cancer Institute (NCI)-sponsored prospective trial to incorporate ctDNA as an integral biomarker for any solid tumor type. Morris presented results at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium.

Awards and honors

James Allison, Ph.D., regental professor and chair of Immunology and director of the James P. Allison Institute at MD Anderson, was inducted into the National Inventor’s Hall of Fame for inventing immune checkpoint blockade therapy. In case you missed it
Read below to catch up on recent MD Anderson press releases.

Cervical cancer rates rising in low-income U.S. counties CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies

- 30 -

END



ELSE PRESS RELEASES FROM THIS DATE:

Retinal photoreceptors use dual pathways to tell brain ‘I’ve seen the light!’

2024-01-25
FOR IMMEDIATE RELEASE Working with mammalian retinal cells, neuroscientists at Johns Hopkins Medicine have shown that, unlike most light-sensing cells (photoreceptors) in the retina, one special type uses two different pathways at the same time to transmit electrical “vision” signals to the brain. The work also reveals that such photoreceptors, according to the researchers, may have ancient origins on the evolutionary scale. This and other findings, published Dec 18, in PNAS, “shed scientific as well as literal light” on a decades-long mystery ...

GSA members call on senate to support higher standards for assisted living facilities

2024-01-25
Speaking today at a hearing of the U.S. Senate Special Committee on Aging, Gerontological Society of America members Jennifer Craft Morgan, PhD, FGSA, and Richard J. Mollot, JD, called on lawmakers to enact policies that enable greater state and national oversight of assisted living facilities, and that bolster the workforce and engagement of residents and care partners. Senators convened the hearing, titled “Assisted Living Facilities: Understanding Long-Term Care Options for Older Adults,” to examine challenges faced by assisted living facility residents. Committee Chair Bob Casey recently sent letters to the CEOs of three ...

American College of Radiology releases joint statement on the use of AI tools in radiology

2024-01-25
Philadelphia, January 25, 2024 – The American College of Radiology® (ACR®), working in close collaboration with four other radiology societies from around the world, have issued a joint statement on the development and use of artificial intelligence (AI) tools in radiology. This groundbreaking joint statement is openly available in ACR’s Journal of the American College of Radiology, published by Elsevier. It explores the potential challenges and ethical and safety concerns related to integrating this new technology into radiology practice. “Developing, Purchasing, Implementing and Monitoring AI Tools ...

Advancements in IBD care: Natural supplements, disease monitoring via sweat and more

2024-01-25
Las Vegas, NV (Jan. 25, 2024) — The Crohn’s & Colitis Foundation® and the American Gastroenterological Association (AGA) are proud to host the annual Crohn’s & Colitis Congress®, taking place on Jan. 25-27, 2024, in Las Vegas. The Crohn’s & Colitis Congress convenes researchers, clinicians, and other professionals involved in the care of patients with inflammatory bowel disease (IBD) to share the latest research breakthroughs and treatment advancements in IBD. During this premier meeting, we’ll review the latest advancements in IBD care that aim to improve the lives of the millions of Americans living with Crohn’s disease ...

These male marsupials give up sleep for sex

These male marsupials give up sleep for sex
2024-01-25
All animals need sleep. When humans or animals don’t get enough, it can lead to trouble paying attention, irritability, and other ill effects. And yet, researchers reporting in the journal Current Biology on January 25 have made the surprising discovery that a small Australian marsupial called an antechinus will sacrifice hours of sleep per night to make more time for sex during the mating season. The researchers say the multi-year study is the first to show direct evidence for this type of sleep restriction in any land-dwelling mammal. It’s a trade-off between sleep and reproduction that they say is likely driven by ...

Dinosaurs might have used feathers on forelimbs and tails to flush and pursue their prey – a new hypothesis integrates morphology, behavior and neurobiology

Dinosaurs might have used feathers on forelimbs and tails to flush and pursue their prey – a new hypothesis integrates morphology, behavior and neurobiology
2024-01-25
What are the origins of wings and tails in birds? This is one of the key questions in the evolution of animals. It has long been accepted that their evolution began in feathered dinosaurs. Some of these dinosaurs had feathers on the tails and small wing-like feathers on their forelimbs (arms). These small wing-like structures called ‘proto-wings’ are composed of special feathers known as pennaceous feathers — the stiff feathers found in the wings and tails of birds. The ancient form of these feathers first emerged in dinosaurs during the Jurassic Period, and these dinosaurs, called ...

Palaeontology: Small dinosaurs flapped their feathers to scare prey

2024-01-25
Small omnivorous and insectivorous dinosaurs may have flapped small, feathered primitive wings to scare prey out of hiding places, according to a study published in Scientific Reports. The authors built a robot dinosaur named Robopteryx to investigate how grasshoppers responded to different potential scaring behaviours, and speculate that the results could help explain why feathered wings evolved before they were capable of flight in some types of dinosaurs. Although the remains of numerous species of feathered dinosaurs have been discovered, so far only members of one group of dinosaurs known as ...

Gaps in the vision screening pathway for school-aged children

2024-01-25
About The Study: The current approach to vision screening in the U.S. may not adequately provide care to all children. At each stage along the care pathway, children from historically marginalized racial and ethnic groups, low-income households, and non–English language speakers experience worse outcomes—they were less likely to receive screening, more likely to be referred for failed screening, and less likely to establish care with a specialist. High referral rates in these vulnerable groups may suggest higher prevalence of undiagnosed conditions or elevated false-positive results from suboptimal screening strategies.  Authors: Isdin Oke, M.D., M.P.H., ...

Suicidal thoughts and trajectories of psychopathological and behavioral symptoms in adolescence

2024-01-25
About The Study: This study of 2,780 adolescents found that persistent withdrawn symptoms and increasing somatic symptoms during early to mid-adolescence were associated with an increased risk of suicidal thoughts in mid-adolescence, even after accounting for comorbid symptoms and confounders. Attention should be paid to the suicidal risk associated with these symptoms, particularly when they persist or increase in the longitudinal follow-up. Authors: Shuntaro Ando, Ph.D., of the University of Tokyo, is the corresponding author.  To ...

An unconventional yeast increases the quality of carbonic maceration wine, rosé wine and orange wine

An unconventional yeast increases the quality of carbonic maceration wine, rosé wine and orange wine
2024-01-25
Carbonic maceration wines are increasingly in demand on the market. They are young red wines in which floral and fresh fruit aromas predominate and they must be consumed within the first year. The best-known example is Beaujolais nouveau in France, but there is also a tradition in La Rioja and Catalonia, especially in the Montsant area and the Conca de Barberà. Research by the URV has found that the quality of these wines can be increased by using an unconventional yeast that considerably improves their organoleptic properties and speeds up the malolactic fermentation process. ...

LAST 30 PRESS RELEASES:

MSU researchers find trees acclimate to changing temperatures

World's first visual grading system developed to combat microplastic fashion pollution

Teenage truancy rates rise in English-speaking countries

Cholesterol is not the only lipid involved in trans fat-driven cardiovascular disease

Study: How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how

New nasal vaccine shows promise in curbing whooping cough spread

Smarter blood tests from MSU researchers deliver faster diagnoses, improved outcomes

Q&A: A new medical AI model can help spot systemic disease by looking at a range of image types

For low-risk pregnancies, planned home births just as safe as birth center births, study shows

Leaner large language models could enable efficient local use on phones and laptops

‘Map of Life’ team wins $2 million prize for innovative rainforest tracking

Rise in pancreatic cancer cases among young adults may be overdiagnosis

New study: Short-lived soda tax reinforces alternative presumptions on tax impacts on consumer behaviors

Fewer than 1 in 5 know the 988 suicide lifeline

Semaglutide eligibility across all current indications for US adults

Can podcasts create healthier habits?

Zerlasiran—A small-interfering RNA targeting lipoprotein(a)

Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss

Oral muvalaplin for lowering of lipoprotein(a)

Revealing the hidden costs of what we eat

New therapies at Kennedy Krieger offer effective treatment for managing Tourette syndrome

American soil losing more nutrients for crops due to heavier rainstorms, study shows

With new imaging approach, ADA Forsyth scientists closely analyze microbial adhesive interactions

Global antibiotic consumption has increased by more than 21 percent since 2016

New study shows how social bonds help tool-using monkeys learn new skills

Modeling and analysis reveals technological, environmental challenges to increasing water recovery from desalination

Navy’s Airborne Scientific Development Squadron welcomes new commander

TāStation®'s analytical power used to resolve a central question about sweet taste perception

NASA awards SwRI $60 million contract to develop next-generation coronagraphs

Reducing antimicrobial resistance: accelerated efforts are needed to meet the EU targets

[Press-News.org] MD Anderson research highlights for January 25, 2024
Featuring combination therapies for KRAS¬-mutant colorectal cancer, prognostic tools for lung cancer, gold nanoparticles, and insights into progression and treatment response